Adroit collaboration: Recipharm teams with solid state formulation firm

By Gareth Macdonald contact

- Last updated on GMT

Adroit collaboration: Recipharm teams with solid state formulation firm

Related tags: Economics, Vice president, President of the united states

Swedish CMO Recipharm has teamed up with formulations and solid state chemistry firm Adroit Science in a strategic collaboration.

The deal – financial terms of which have not been disclosed – will see Adroit work with Recipharm’spharmaceutical development services business. 

Carl-Johan Spak, Executive Vice President, development and technology at Recipharm, predicted that the partnership would increase efficiency and help customers get to market faster.

“Adroit Science AB has fast established itself as one of the leading providers of solid state characterisation services in Northern Europe. Indeed, we can offer an even better service to our customers through this collaboration, including complete development from molecule to product​.”

Related topics: Contract Manufacturing

Related news

Show more

Related products

show more

baxter_bloomington_facility_larger

Sterile Injectables Contract Manufacturing

Baxter BioPharma Solutions | 02-Apr-2018 | Product Brochure

Baxter BioPharma Solutions' award-winning facility in Bloomington, Indiana, USA, is a leader in sterile contract manufacturing of injectable products.

lyo_development

Lyophilization Scale-Up and Tech Transfer

Baxter BioPharma Solutions | 12-Mar-2018 | Technical / White Paper

There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...

How will Brexit affect the Pharmaceutical Industry?

How will Brexit affect the Pharmaceutical Industry?

Source BioScience Ltd | 08-Mar-2018 | Technical / White Paper

Have you prepared your strategy for the outcome of Brexit to ensure that you can continue to supply the UK market?
Source BioScience is a CRO with...

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...

Related suppliers

Follow us

Products

View more